Tradestie Institutional Equity Comparison Engine

BIIB vs TECH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BIIB Overall Edge

BIIB Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biogen Inc. Common Stock (BIIB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TECH counters with relative strength in Valuation. Fundamentally, BIIB trades at 15.6x Forward P/E with 23.5% operating margin (+10.6% YoY revenue) versus TECH at 42.8x Forward P/E and 21.7% operating margin (+4.6% YoY). In options structure, BIIB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against TECH sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TECH
BIIB 15.6x vs TECH 42.8x Fwd P/E
Growth & Margin Winner BIIB
Op Margin 23.5% vs 21.7% ยท YoY +10.6% vs +4.6%
Momentum & Technical Winner BIIB
1Y +53.4% vs +19.8% ยท 52W Pos 92% vs 100%
Options & Structure Winner BIIB
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (6th %ile IV)
BIIB NASDAQ
Biogen Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$252.72
-0.27% 1D
Market Cap $37.0B
1M Return +8.63%
1Y Return +53.41%
Forward P/E 15.6x
Unified AI Score
50.2 / 100 HOLD
Tech 45.0 Fund 52.0 Flow 64.0 Mom 50.0
TECH NASDAQ
Bio-Techne Corp.
Biological Products, (No Disgnostic Substances)
$72.79
-0.01% 1D
Market Cap $11.4B
1M Return +0.3%
1Y Return +19.82%
Forward P/E 42.8x
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIIB +53.41% TECH +19.82% Spread: +33.59 pp (BIIB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIIB TTM Op. Margin: 23.5% TECH TTM Op. Margin: 21.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIIB vs TECH. Trailing 12-month operating profitability (BIIB 23.5% vs TECH 21.7%) and valuation multiples (BIIB 15.6x vs TECH 42.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIIB (4) vs TECH (6)
Institutional Metric BIIB TECH Criterion Row Winner
Market Capitalization Scale $37.0B $11.4B Larger Scale BIIB
Trailing P/E Ratio Valuation 109.9x 66.8x Lower Multiple TECH
Forward P/E Ratio Valuation 15.6x 42.8x Lower Multiple BIIB
Revenue Growth (YoY) Growth +10.6% +4.6% Higher Growth BIIB
Operating Margin (TTM) Profitability 23.5% 21.7% Higher Margin BIIB
Net Profit Margin Profitability 3.4% 14.0% Higher Margin TECH
Return on Equity (ROE) Capital Efficiency 1.9% 8.3% Higher ROE TECH
52-Week Range Position Momentum 92% ($160โ€“$261) 100% ($43โ€“$73) Stronger Trend TECH
Beta / 30D Volatility Risk Regime 0.27ฮฒ ยท 36% Vol 0.37ฮฒ ยท 1% Vol Lower Realized Risk TECH
Unified Institutional Score Composite Signal 50.2 / 100 (HOLD) 52.4 / 100 (HOLD) Higher Composite TECH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIIB vs TECH Buy Guide
BIIB CONSOLIDATION
17d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live BIIB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TECH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live TECH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIIB nor TECH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.